ATE444362T1 - Onkogen, davon abgeleitetes rekombinantes protein und dessen verwendung - Google Patents

Onkogen, davon abgeleitetes rekombinantes protein und dessen verwendung

Info

Publication number
ATE444362T1
ATE444362T1 AT04001078T AT04001078T ATE444362T1 AT E444362 T1 ATE444362 T1 AT E444362T1 AT 04001078 T AT04001078 T AT 04001078T AT 04001078 T AT04001078 T AT 04001078T AT E444362 T1 ATE444362 T1 AT E444362T1
Authority
AT
Austria
Prior art keywords
oncogenic protein
oncogene
polynucleotide
protein derived
seq
Prior art date
Application number
AT04001078T
Other languages
English (en)
Inventor
Akira Saito
Masahiko Kuroda
Original Assignee
Nec Corp
Masahiko Kuroda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nec Corp, Masahiko Kuroda filed Critical Nec Corp
Application granted granted Critical
Publication of ATE444362T1 publication Critical patent/ATE444362T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04001078T 2003-01-20 2004-01-20 Onkogen, davon abgeleitetes rekombinantes protein und dessen verwendung ATE444362T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003011478A JP3792655B2 (ja) 2003-01-20 2003-01-20 新規な癌遺伝子、該癌遺伝子由来の組換えタンパク質、およびそれらの用途

Publications (1)

Publication Number Publication Date
ATE444362T1 true ATE444362T1 (de) 2009-10-15

Family

ID=32588600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04001078T ATE444362T1 (de) 2003-01-20 2004-01-20 Onkogen, davon abgeleitetes rekombinantes protein und dessen verwendung

Country Status (8)

Country Link
US (4) US7358350B2 (de)
EP (1) EP1439229B9 (de)
JP (1) JP3792655B2 (de)
CN (3) CN1982324B (de)
AT (1) ATE444362T1 (de)
DE (1) DE602004023340D1 (de)
ES (1) ES2331995T3 (de)
SG (1) SG135939A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1884522A1 (de) * 2006-07-31 2008-02-06 Boehringer Ingelheim International GmbH Antikörper gegen einer Polo like Kinase 1 Phosphorylierungsstelle von dem menschlischen Cohesin Wapl
CN102154214B (zh) * 2011-01-29 2012-10-17 谢幸 一种新的宫颈癌细胞株(N-Caski)及其构建方法和应用
US20200141921A1 (en) * 2016-12-27 2020-05-07 Sumitomo Chemical Company, Limited Evaluation method and selection method for induced pluripotent stem cells, and production method for induced pluripotent stem cells
CN110491450B (zh) * 2019-08-23 2023-05-16 深圳市新合生物医疗科技有限公司 肿瘤新生抗原预测平台及其应用
CN113057146B (zh) * 2021-04-06 2022-03-18 西南大学 家蚕BmUAP56基因的应用
CN118516350A (zh) * 2023-08-21 2024-08-20 陕西省人民医院(陕西省临床医学研究院) 一种人hWAPL基因的shRNA干扰序列及其构建与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3091870B2 (ja) 1989-12-19 2000-09-25 アメリカ合衆国 肝細胞の癌の癌遺伝子
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AU6496599A (en) 1998-09-11 2000-04-03 California Institute Of Technology Regulation of her2/neu oncogene expression by synthetic polyamides
AU2002500A (en) 1999-01-14 2000-08-01 Kyowa Hakko Kogyo Co. Ltd. Novel protein
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP4520551B2 (ja) 1999-07-14 2010-08-04 パナソニック株式会社 駆動回路および表示装置
JP4426023B2 (ja) 1999-08-20 2010-03-03 第一三共株式会社 大腸癌抑制遺伝子関連蛋白質
AU3574900A (en) * 1999-10-15 2001-04-23 Jin Woo Kim Human cervical cancer 1 protooncogene and protein encoded therein
US20040072154A1 (en) * 2000-12-22 2004-04-15 Morris David W. Novel compositions and methods for cancer
WO2003008583A2 (en) 2001-03-02 2003-01-30 Sagres Discovery Novel compositions and methods for cancer
KR20020088738A (ko) * 2001-05-21 2002-11-29 주식회사 아미노젠 암세포 증식 억제 단백질 e2를 생산하는 재조합아데노바이러스 벡터 및 이의 용도
WO2003087768A2 (en) * 2002-04-12 2003-10-23 Mitokor Targets for therapeutic intervention identified in the mitochondrial proteome
EP2305813A3 (de) * 2002-11-14 2012-03-28 Dharmacon, Inc. Funktionale und hyperfunktionale siRNA

Also Published As

Publication number Publication date
US20060217342A1 (en) 2006-09-28
US7893246B2 (en) 2011-02-22
SG135939A1 (en) 2007-10-29
EP1439229B9 (de) 2010-02-24
EP1439229B1 (de) 2009-09-30
JP2004222539A (ja) 2004-08-12
US7358350B2 (en) 2008-04-15
HK1069850A1 (en) 2005-06-03
US20110213128A1 (en) 2011-09-01
DE602004023340D1 (de) 2009-11-12
JP3792655B2 (ja) 2006-07-05
HK1101095A1 (zh) 2007-10-05
US20040248155A1 (en) 2004-12-09
US20090042830A1 (en) 2009-02-12
CN1982324B (zh) 2010-06-09
US7432358B2 (en) 2008-10-07
CN1295331C (zh) 2007-01-17
ES2331995T3 (es) 2010-01-22
CN101608182B (zh) 2011-06-15
CN1982324A (zh) 2007-06-20
CN101608182A (zh) 2009-12-23
EP1439229A2 (de) 2004-07-21
CN1550550A (zh) 2004-12-01
EP1439229A3 (de) 2004-12-01

Similar Documents

Publication Publication Date Title
IL210455A (en) A polypeptide for reducing mammalian signaling 13il, and using a polypeptide to produce a drug for up-regulating gene expression 2ra13-il in mammals
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
ATE417595T1 (de) Keratin-bindende polypeptide
ATE430197T1 (de) Fibroblasten wachstumsfaktor-ähnliche polypeptide
DK2071028T3 (da) HLA-DR-bindende antigenpeptid afledt af WT1
ATE540973T1 (de) Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung
TWI265168B (en) C peptide for improved preparation of insulin and insulin analogs
ATE485050T1 (de) Verwendung von p43 zur förderung der wundheilung
DE602004023340D1 (de) Onkogen, davon abgeleitetes rekombinantes Protein und dessen Verwendung
ATE240349T1 (de) Peptide zur inhibierung von hpv e6-proteinen
ATE521626T1 (de) Fusionsprotein zur inhibierung von gebärmutterhalskrebs
ATE389720T1 (de) Nierenspezifischer urattransporter und dessen gen
DK1602721T3 (da) Phospholipase A SB 2 /SB stammende fra Koji-skimmelsvamp
MXPA05009954A (es) Familia de proteinas secretadas.
DK1673391T3 (da) Modificeret cDNA til höje ekspressionsniveauer af faktor VIII og dens derivater
ATE423200T1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
DK2186898T3 (da) Blomstrings-induktion
GB0520568D0 (en) Receptor
DE60325227D1 (de)
WO2004042043A3 (en) Crystal structures of bacterial ribulose-phosphate 3-epimerases
EP1467207A4 (de) Screening-verfahren
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
JP2002335976A5 (de)
DE50310131D1 (de) Peptide mit hohem cysteingehalt
WO2004069989A3 (en) Novel purified phosphodiesterase polypeptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties